ASIA CEO Community

Dr. Zou Bin is the founder and CEO of Tetris Therapeutics and an adjunct associate professor at National University of Singapore and Nanyang Technological University. As a serial entrepreneur with a plethora of research and leadership experience, Zou Bin is passionate about translating new technologies into therapeutics to meet unmet medical needs.
Tetris Therapeutics is a Singapore based biotechnology company focusing on the development of antibody drug conjugate (ADC) therapies to revolutionise cancer treatments. Leveraging on proprietary technologies, Tetris Therapeutics is developing a robust pipeline of ADC candidates to address unmet medical needs for new treatment options.